Clinical Trials Directory

Trials / Completed

CompletedNCT00383344

Use of FDG PET/CT to Evaluate Crohn Disease

Phase II Study on the Role of the Positron Emission Tomography Combined With CT Scan for the Evaluation on Crohn Disease

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Eric Turcotte · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study will permit to determine the role of FDG PET/CT to diagnose Crohn Disease and recurrence of Crohn disease after having compared results of PET/CT's with results of exams routinely performed(colonoscopy and bowel follow through).

Detailed description

Crohn disease is an inflammatory disease of the digestive system that may affect the small and large intestines. Remission and recurrence clinically characterized its development. When recurrence occurs, a careful examination is necessary in order to determine the extent and the severity of the disease. Actual exams performed are invasive and uncomfortable(colonoscopy and bowel follow through). Compare to these exams, PET/CT is less fierce to undergo and has less risks. Two groups are proposed in this project: 15 patients will be enroll in the active disease group and 15 patients will be enroll in the remission group. In regards of the area and the extent of the disease,PET/CT exams shall provide similar information than what usual tests provide. PET/CT exams shall also provide more information in order to better differentiate inflammatory stenosis from scars stenosis especially located in the small intestine.

Conditions

Interventions

TypeNameDescription
PROCEDUREFDG PET/CT

Timeline

Start date
2006-10-01
Primary completion
2007-05-01
Completion
2007-05-01
First posted
2006-10-03
Last updated
2024-12-09

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00383344. Inclusion in this directory is not an endorsement.